Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
First Claim
Patent Images
1. A method of producing a population from neural tissue enriched for human central nervous system stem cells (CNS-SC), progenitors, or a combination thereof, which can initiate neurospheres (NS-IC), comprising:
- a) contacting neural or neural derived cells with a monoclonal antibody that binds to CD49f; and
b) selecting said neural or neural-derived cells that bind to the monoclonal antibody;
wherein the selected cells are enriched for human CNS-SC.
1 Assignment
0 Petitions
Accused Products
Abstract
Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagents that bind to cell surface markers are provided.
-
Citations
43 Claims
-
1. A method of producing a population from neural tissue enriched for human central nervous system stem cells (CNS-SC), progenitors, or a combination thereof, which can initiate neurospheres (NS-IC), comprising:
-
a) contacting neural or neural derived cells with a monoclonal antibody that binds to CD49f; and
b) selecting said neural or neural-derived cells that bind to the monoclonal antibody;
wherein the selected cells are enriched for human CNS-SC. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
- 10. A method for producing a population enriched for human central nervous system stem cells (CNS-SC), progenitors, or a combination thereof, which can initiate neurospheres (NS-IC) or an adherent cell culture comprising selecting from a population of neural or neural-derived cells for those cells that are CD49f+.
- 14. A method for enriching from a population of neural cells for the populations of neurosphere initiating stem cell (NS-IC) fraction, comprising selecting from the neural cells for cells that express CD49f by binding to monoclonal antibody GoH3 or monoclonal antibody 4F10, wherein the selected cells are enriched in the fraction of NS-IC as compared with the population of neural cells.
-
16. A method for isolating a neurosphere initiating stem cell (NS-IC) from primary neural tissues, comprising:
-
a) selecting from a population of neural or neural-derived cells for cells that are CD49f+;
b) removing the cells that are CD24+, wherein the remaining cells are CD24−
/lo;
c) introducing the cells remaining after step b) to a serum-free culture medium containing one or more growth factors selected from the group consisting of leukemia inhibitory factor (LIF), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF;
FGF-2), and combinations thereof; and
d) proliferating the remaining cells in the culture medium.
-
-
17. A method for producing a population enriched for human central nervous system stem cells (CNS-SC) which can initiate neurospheres (NS-IC) comprising selecting from neural or neural-derived cells for cells that are CD49f+ and bind to an anti-CD49f antibody selected from the group consisting of monoclonal antibody GoH3 and monoclonal antibody 4F10, to produce a population enriched for CNS-SC, wherein the selecting is by attachment to and disattachment from solid phase.
- 18. An antibody that specifically binds to the CD49f antigen, wherein said CD49f antigen specifically binds to the monoclonal antibody GoH3 or to the monoclonal antibody 4F10.
-
21. A method for the enrichment of human central nervous system neural stem cells (CNS-SC), progenitors, or a combination thereof, which can initiate neurospheres (NS-IC), said method comprising:
-
a) combining a population of neural or neural-derived cells with a reagent that specifically binds to the CD49f antigen; and
b) selecting for those cells that bind to the reagent, wherein the selected cells are enriched for CNS-SC, progenitors, or a combination thereof. - View Dependent Claims (22)
-
- 23. A method for producing a population enriched for human central nervous system stem cells (CNS-SC), progenitors, or a combination thereof, which can initiate neurospheres (NS-IC), comprising selecting from neural or neural-derived cells for those cells that express CD49f and bind to monoclonal antibody GoH3 or to monoclonal antibody 4F10, to produce a population enriched for CNS-SC, progenitors, or a combination thereof.
-
28. A method for producing a population enriched for human central nervous system stem cells (CNS-SC), progenitors, or a combination thereof, which can initiate neurospheres (NS-IC), wherein the population is obtained from primary neural tissues, the method comprising selecting from a population of neural or neural-derived cells for cells that are CD49f+, the method further comprising the steps of further enriching for CNS-SC, progenitors, or a combination thereof, by further selecting for those cells that are CD24−
- /lo.
-
29. A method for isolating a neurosphere initiating stem cell (NS-IC), comprising:
-
a) selecting from a population of neural or neural-derived cells for at least one selected cell that binds to monoclonal antibody GoH3 or to monoclonal antibody 4F10;
b) introducing at least one selected cell to a serum free culture medium containing one or more growth factors selected from the group consisting of leukemia inhibitory factor (LIF), epidermal growth factor (EGF), basic fibroblast growth factor (FGF-2) and combinations thereof; and
c) proliferating the at least one selected cell in the culture medium.
-
-
30. A method of producing further subdivided populations enriched for human central nervous system stem cells (CNS-SC), progenitors, or a combination thereof, which can initiate neurospheres (NS-IC), comprising:
-
a) contacting neural or neural derived cells with a monoclonal antibody that binds to CD15; and
b) selecting said neural or neural-derived cells that are CD15−
/lo or CD15+;
wherein the selected cells are enriched for human CNS-SC, progenitors, or a combination thereof and wherein the CD15−
/lo cells are a subset of the CD133+CD24−
/lo population. - View Dependent Claims (31, 32, 33, 34, 37, 38)
-
- 35. An antibody that specifically binds to the CD15 antigen, wherein said CD15 antigen specifically binds to the monoclonal antibody MMA and wherein said antibody is a monoclonal antibody produced by a hybridoma cell line.
- 39. A method for enriching from a population of neural cells for the populations of neurosphere initiating stem cell (NS-IC) fraction, comprising selecting from the neural cells for cells that bind to monoclonal antibody MMA, wherein the selected cells are enriched in the fraction of NS-IC as compared with the population of neural cells.
-
41. A method for isolating a neurosphere initiating stem cell (NS-IC), comprising:
-
a) selecting from a population of neural or neural-derived cells for cells that are CD15+ or CD15−
/lo, wherein the CD15−
/lo cells are a subset of the CD133+CD24-/lo population;
b) removing the cells that are SC20+, wherein the remaining cells are SC20−
/lo;
c) introducing the remaining cells to a serum-free culture medium containing one or more growth factors selected from the group consisting of leukemia inhibitory factor (LIF), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF;
FGF-2), and combinations thereof; and
d) proliferating the remaining cells in the culture medium.
-
-
42. A method for the enrichment of human central nervous system neural stem cells (CNS-SC), progenitors, or a combination thereof, which can initiate neurospheres (NS-IC), said method comprising:
-
a) combining a population of neural or neural-derived cells with a reagent that specifically binds to the CD15 antigen; and
b) selecting for those cells that are CD15+ or CD15−
/lo, wherein the CD15−
/lo cells are a subset of the CD133+CD24−
/lo,wherein the selected cells are enriched for CNS-SC, progenitors, or a combination thereof. - View Dependent Claims (43)
-
Specification